Cubist Systematic Strategies, LLC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 64 filers reported holding CTI BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2022$828,142
-46.1%
137,794
-47.8%
0.01%
-44.4%
Q3 2022$1,536,000
+303.1%
263,956
+313.6%
0.01%
+350.0%
Q2 2022$381,000
-84.7%
63,823
-88.0%
0.00%
-90.5%
Q1 2022$2,483,000
+4498.1%
531,600
+2820.4%
0.02%
+2000.0%
Q3 2021$54,000
-57.8%
18,203
-64.5%
0.00%0.0%
Q2 2021$128,000
+75.3%
51,287
+105.0%
0.00%0.0%
Q1 2021$73,00025,0210.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,068,191$4,719,0009.14%
CAXTON CORP 619,460$719,0000.76%
BVF INC/IL 6,929,690$8,038,0000.50%
NEA Management Company, LLC 7,140,450$8,283,0000.33%
Orbimed Advisors 9,520,600$11,044,0000.16%
Renaissance Technologies 2,103,792$2,440,0000.00%
Paloma Partners Management Co 30,289$35,0000.00%
WEDBUSH SECURITIES INC 12,600$15,0000.00%
HRT FINANCIAL LP 19,710$22,0000.00%
FIRST MANHATTAN CO. LLC. 33$00.00%
View complete list of CTI BIOPHARMA CORP shareholders